Eurazeo has announced an investment, via its managed fund Nov Santé Actions Non Cotées, in the capital of Moria, as part of a new LBO carried out by its historical sponsor Nexicap Partners around its CEO Bruno Chermette and his team.

The investment group thus becomes a new minority shareholder in this company, which designs, manufactures and markets equipment, micro-instruments and consumables for hospital ophthalmic surgeons.

Founded in 1820 and based in Bourbon-l'Archambault (Allier) with a second production plant in Padova, Italy, Moria has sales subsidiaries in the USA, Japan, China and Italy, and a worldwide network of 180 distributors.

Copyright (c) 2024 CercleFinance.com. All rights reserved.